Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

CPAYXLAB

Corpay, Inc.

CPAY · $408.46

60Good

Exascale Labs Holdings Inc.

XLAB · $3.35

76Strong

Area by area

Overall Quant Score

How does it look overall? (out of 100)

CPAY

60/100

XLAB

76/100

Quality

Is it a profitable, well-run business?

CPAY

8.2/10

XLAB

n/a

Growth

Is the company growing?

CPAY

5.2/10

XLAB

n/a

Valuation

Is the price reasonable? (higher = cheaper)

CPAY

7.7/10

XLAB

n/a

Risk

How risky are the shares? (higher = lower risk)

CPAY

5.8/10

XLAB

4.2/10

Momentum

Is the share price trending up?

CPAY

9.4/10

XLAB

7.6/10

Financial strength

Is the balance sheet healthy?

CPAY

1.8/10

XLAB

n/a

The balanced view

Model-generated

Corpay, Inc.

This company scores above average, with a positive price trend and strong profitability, although its balance sheet looks stretched.

Leads on: quality, growth, valuation, risk, momentum, financial strength

Best feature: positive price trend (Trend alignment (50/200 SMA): 3/3)

Watch out: balance sheet is stretched (Altman Z-Score: 1.61)

Exascale Labs Holdings Inc.

There isn't enough financial data to give this stock a reliable overall score.

Leads on: no single area

Best feature: positive price trend (RSI (14): 57.2)

Watch out: shares can be volatile (Largest 1Y drawdown: -85%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.